Targeted and reversible blood-retinal barrier disruption via focused ultrasound and microbubbles

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Park, Juyoung ^a   Zhang, Yongzhi ^a   Vykhodtseva, Natalia ^a   Akula, James D ^b   McDannold, Nathan J ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PERFLUTREN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD RETINA BARRIER; BLOOD VESSEL PERMEABILITY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; FOCUSED ULTRASOUND; HISTOLOGY; MALE; MICROBUBBLE; NON INVASIVE PROCEDURE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; RAT; RETINA INJURY; SPRAGUE DAWLEY RAT; ULTRASOUND; ULTRASOUND TRANSDUCER; VITREOUS BODY;

ANIMALS; BLOOD-RETINAL BARRIER; CAPILLARY PERMEABILITY; CONTRAST MEDIA; DRUG DELIVERY SYSTEMS; MAGNETIC RESONANCE IMAGING; MALE; MICROBUBBLES; RATS; RATS, SPRAGUE-DAWLEY; RETINA; SONICATION;

EID: 84865054121     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0042754     Document Type: Article

References (49)

1. Bleeker GM, van Haeringen NJ, Maas ER, Glasius E, (1968) Selective properties of the vitreous barrier. Exp Eye Res 7: 37-46.
2. Cunha-Vaz JG, (2004) The blood-retinal barriers system. Basic concepts and clinical evaluation. Exp Eye Res 78: 715-721.
3. Mannermaa E, Vellonen KS, Urtti A, (2006) Drug transport in corneal epithelium and blood-retina barrier: emerging role of transporters in ocular pharmacokinetics. Adv Drug Deliv Rev 58: 1136-1163.
4. Duvvuri S, Majumdar S, Mitra AK, (2003) Drug delivery to the retina: challenges and opportunities. Expert Opin Biol Ther 3: 45-56.
5. Geroski DH, Edelhauser HF, (2000) Drug delivery for posterior segment eye disease. Invest Ophthalmol Vis Sci 41: 961-964.
6. Campbell M, Nguyen AT, Kiang AS, Tam LC, Gobbo OL, et al. (2009) An experimental platform for systemic drug delivery to the retina. Proc Natl Acad Sci U S A 106: 17817-17822.
7. Pardridge WM, (2005) Molecular biology of the blood-brain barrier. Mol Biotechnol 30: 57-70.
8. Thrimawithana TR, Young S, Bunt CR, Green C, Alany RG, (2011) Drug delivery to the posterior segment of the eye. Drug Discov Today 16: 270-277.
9. Peyman GA, Lad EM, Moshfeghi DM, (2009) Intravitreal injection of therapeutic agents. Retina 29: 875-912.
10. Wu H, Chen TC, (2009) The effects of intravitreal ophthalmic medications on intraocular pressure. Semin Ophthalmol 24: 100-105.
11. Dalkara D, Kolstad KD, Caporale N, Visel M, Klimczak RR, et al. (2009) Inner limiting membrane barriers to AAV-mediated retinal transduction from the vitreous. Mol Ther 17: 2096-2102.
12. Hynynen K, McDannold N, Vykhodtseva N, Jolesz FA, (2001) Noninvasive MR imaging-guided focal opening of the blood-brain barrier in rabbits. Radiology 220: 640-646.
13. Baseri B, Choi JJ, Tung YS, Konofagou EE, (2010) Multi-modality safety assessment of blood-brain barrier opening using focused ultrasound and definity microbubbles: a short-term study. Ultrasound Med Biol 36: 1445-1459.
14. Hynynen K, McDannold N, Vykhodtseva N, Raymond S, Weissleder R, et al. (2006) Focal disruption of the blood-brain barrier due to 260-kHz ultrasound bursts: a method for molecular imaging and targeted drug delivery. J Neurosurg 105: 445-454.
15. McDannold N, Vykhodtseva N, Hynynen K, (2006) Targeted disruption of the blood-brain barrier with focused ultrasound: association with cavitation activity. Phys Med Biol 51: 793-807.
16. Kinoshita M, McDannold N, Jolesz FA, Hynynen K, (2006) Noninvasive localized delivery of Herceptin to the mouse brain by MRI-guided focused ultrasound-induced blood-brain barrier disruption. Proc Natl Acad Sci U S A 103: 11719-11723.
17. Treat L, Zhang Y, McDannold N, Hynynen K (2008) MRI-guided focused ultrasound-enhanced chemotherapy of 9L rat gliosarcoma: Survival study. In: Proc16th Scientific Meeting, International Society for Magnetic Resonance in Medicine pp 71. Toronto, Canada.
18. Liu HL, Hua MY, Chen PY, Chu PC, Pan CH, et al. (2010) Blood-brain barrier disruption with focused ultrasound enhances delivery of chemotherapeutic drugs for glioblastoma treatment. Radiology 255: 415-425.
19. Hynynen K, McDannold N, Sheikov NA, Jolesz FA, Vykhodtseva N, (2005) Local and reversible blood-brain barrier disruption by noninvasive focused ultrasound at frequencies suitable for trans-skull sonications. Neuroimage 24: 12-20.
20. Sheikov N, McDannold N, Sharma S, Hynynen K, (2008) Effect of focused ultrasound applied with an ultrasound contrast agent on the tight junctional integrity of the brain microvascular endothelium. Ultrasound Med Biol 34: 1093-1104.
21. Sheikov N, McDannold N, Jolesz F, Zhang YZ, Tam K, et al. (2006) Brain arterioles show more active vesicular transport of blood-borne tracer molecules than capillaries and venules after focused ultrasound-evoked opening of the blood-brain barrier. Ultrasound Med Biol 32: 1399-1409.
22. Park J, Fan Z, Deng CX, (2011) Effects of shear stress cultivation on cell membrane disruption and intracellular calcium concentration in sonoporation of endothelial cells. J Biomech 44: 164-169.
23. Park J, Fan Z, Kumon RE, El-Sayed ME, Deng CX, (2010) Modulation of intracellular Ca2+ concentration in brain microvascular endothelial cells in vitro by acoustic cavitation. Ultrasound Med Biol 36: 1176-1187.
24. Jalali S, Huang Y, Dumont DJ, Hynynen K, (2010) Focused ultrasound-mediated bbb disruption is associated with an increase in activation of AKT: experimental study in rats. BMC Neurol 10: 114.
25. Forbes MM, Steinberg RL, O'Brien WD Jr, (2008) Examination of inertial cavitation of Optison in producing sonoporation of chinese hamster ovary cells. Ultrasound Med Biol 34: 2009-2018.
26. Fischer K, McDannold NJ, Zhang Y, Kardos M, Szabo A, et al. (2009) Renal ultrafiltration changes induced by focused US. Radiology 253: 697-705.
27. Lafon C, Khokhlova VA, Kaczkowski PJ, Bailey MR, Sapozhnikov OA, et al. (2006) Use of a bovine eye lens for observation of HIFU-induced lesions in real-time. Ultrasound in Medicine & Biology 32: 1731-1741.
28. Pardridge WM, (2005) The blood-brain barrier: bottleneck in brain drug development. Neuro Rx 2: 3-14.
29. Cunha-Vaz JG, (1997) The blood-ocular barriers: past, present, and future. Doc Ophthalmol 93: 149-157.
30. Aptel F, Charrel T, Lafon C, Romano F, Chapelon JY, et al. (2011) Miniaturized high-intensity focused ultrasound device in patients with glaucoma: a clinical pilot study. Invest Ophthalmol Vis Sci 52: 8747-8753.
31. Burgess SE, Silverman RH, Coleman DJ, Yablonski ME, Lizzi FL, et al. (1986) Treatment of glaucoma with high-intensity focused ultrasound. Ophthalmology 93: 831-838.
32. Coleman DJ, Lizzi FL, Driller J, Rosado AL, Burgess SE, et al. (1985) Therapeutic ultrasound in the treatment of glaucoma. II. Clinical applications. Ophthalmology 92: 347-353.
33. Coleman DJ, Lizzi FL, Jakobiec FA, (1978) Therapeutic ultrasound in the production of ocular lesions. Am J Ophthalmol 86: 185-192.
34. Lizzi FL, Coleman DJ, Driller J, Franzen LA, Jakobiec FA, (1978) Experimental, ultrasonically induced lesions in the retina, choroid, and sclera. Invest Ophthalmol Vis Sci 17: 350-360.
35. Sterk CC, Borsje RA, van Delft JL, (1992) The effect of high-intensity focused ultrasound on intraocular pressure in therapy-resistant glaucoma 3-4 months and 1 year after treatment. Int Ophthalmol 16: 401-404.
36. Lizzi FL, Coleman DJ, (2004) History of ophthalmic ultrasound. J Ultrasound Med 23: 1255-1266.
37. Zderic V, Clark JI, Martin RW, Vaezy S, (2004) Ultrasound-enhanced transcorneal drug delivery. Cornea 23: 804-811.
38. Sonoda S, Tachibana K, Uchino E, Yamashita T, Sakoda K, et al. (2007) Inhibition of melanoma by ultrasound-microbubble-aided drug delivery suggests membrane permeabilization. Cancer Biol Ther 6: 1276-1283.
39. Lee NG, Berry JL, Lee TC, Wang AT, Honowitz S, et al. (2011) Sonoporation enhances chemotherapeutic efficacy in retinoblastoma cells in vitro. Invest Ophthalmol Vis Sci 52: 3868-3873.
40. Silverman RH, Vogelsang B, Rondeau MJ, Coleman DJ, (1991) Therapeutic ultrasound for the treatment of glaucoma. Am J Ophthalmol 111: 327-337.
41. Miszalok V, Fritzsch T, Wollensak J, (1986) Contrast echography of the eye and orbit. Ophthalmologica 193: 231-235.
42. Montanari P, Bianchi R, Oldani A, Ratiglia R, Raiteri M, et al. (2000) Study of optic nerve head perfusion in glaucomatous patients by color Doppler imaging with a contrast agent. Acta Ophthalmol Scand Suppl: 35-36.
43. Xie W, Liu S, Su H, Wang Z, Zheng Y, et al. (2010) Ultrasound microbubbles enhance recombinant adeno-associated virus vector delivery to retinal ganglion cells in vivo. Acad Radiol 17: 1242-1248.
44. Zheng X, Ji P, Hu J, (2011) Sonoporation using microbubbles promotes lipofectamine-mediated siRNA transduction to rat retina. Bosn J Basic Med Sci 11: 147-152.
45. Hirokawa T, Karshafian R, Pavlin CJ, Burns PN, (2007) Insonation of the eye in the presence of microbubbles: preliminary study of the duration and degree of vascular bioeffects-work in progress. J Ultrasound Med 26: 731-738.
46. McDannold N, Vykhodtseva N, Hynynen K, (2008) Blood-brain barrier disruption induced by focused ultrasound and circulating preformed microbubbles appears to be characterized by the mechanical index. Ultrasound Med Biol 34: 834-840.
47. McDannold N, Vykhodtseva N, Hynynen K, (2008) Effects of acoustic parameters and ultrasound contrast agent dose on focused-ultrasound induced blood-brain barrier disruption. Ultrasound Med Biol 34: 930-937.
48. Raymond SB, Skoch J, Hynynen K, Bacskai BJ, (2007) Multiphoton imaging of ultrasound/Optison mediated cerebrovascular effects in vivo. J Cereb Blood Flow Metab 27: 393-403.
49. O'Reilly M, Hynynen K, (2012) Blood-brain barrier: real-time feedback-controlled focused ultrasound disruption by using an acoustic emissions-based controller. Radiology 263: 96-106.